Mawer Investment Management Ltd. reduced its stake in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 25.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 348,154 shares of the company’s stock after selling 121,765 shares during the period. Mawer Investment Management Ltd.’s holdings in Ryan Specialty were worth $12,882,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the stock. Allworth Financial LP raised its stake in shares of Ryan Specialty by 70.0% during the second quarter. Allworth Financial LP now owns 787 shares of the company’s stock valued at $30,000 after acquiring an additional 324 shares in the last quarter. Fortitude Family Office LLC purchased a new stake in shares of Ryan Specialty in the third quarter valued at approximately $34,000. Parallel Advisors LLC boosted its holdings in shares of Ryan Specialty by 54.9% in the first quarter. Parallel Advisors LLC now owns 1,013 shares of the company’s stock valued at $34,000 after purchasing an additional 359 shares during the period. Jacobi Capital Management LLC bought a new position in Ryan Specialty in the third quarter worth approximately $42,000. Finally, Integrated Wealth Concepts LLC bought a new position in Ryan Specialty in the second quarter worth approximately $73,000. 84.82% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Ryan Specialty
In related news, CEO Benjamin Wuller sold 50,000 shares of the company’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $47.31, for a total transaction of $2,365,500.00. Following the completion of the sale, the chief executive officer directly owned 94,095 shares in the company, valued at $4,451,634.45. This represents a 34.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 52.03% of the stock is owned by company insiders.
Ryan Specialty Stock Up 1.4%
NYSE:RYAN traded up $0.65 during trading hours on Friday, reaching $46.80. The company’s stock had a trading volume of 3,119,407 shares, compared to its average volume of 2,198,085. The stock has a 50 day moving average price of $41.17 and a two-hundred day moving average price of $39.00. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $11.77 billion, a P/E ratio of 57.78, a price-to-earnings-growth ratio of 0.97 and a beta of 0.54. Ryan Specialty Holdings Inc. has a 12 month low of $29.28 and a 12 month high of $58.91.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.02. Ryan Specialty had a return on equity of 47.77% and a net margin of 8.25%. The business had revenue of $789.96 million for the quarter, compared to analysts’ expectations of $792.99 million. During the same quarter last year, the firm earned $0.47 EPS. Equities analysts predict that Ryan Specialty Holdings Inc. will post 2.18 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 24th. Stockholders of record on Tuesday, November 10th will be given a $0.13 dividend. This represents a $0.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, November 10th. Ryan Specialty’s payout ratio is presently 64.20%.
Analyst Ratings Changes
Several research firms have commented on RYAN. Morgan Stanley raised their price objective on Ryan Specialty from $48.00 to $50.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. Barclays lifted their target price on Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Keefe, Bruyette & Woods upped their target price on Ryan Specialty from $48.00 to $54.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. The Goldman Sachs Group increased their price target on Ryan Specialty from $40.00 to $45.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Finally, Piper Sandler dropped their price target on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 6th. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Ryan Specialty has a consensus rating of “Hold” and a consensus price target of $52.62.
Check Out Our Latest Analysis on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.
Read More
- Five stocks we like better than Ryan Specialty
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
